Author Question: The identification of deficits in working memory is particularly interesting with regard to ... (Read 48 times)

fahad

  • Hero Member
  • *****
  • Posts: 570
The identification of deficits in working memory is particularly interesting with regard to schizophrenia because it links to other evidence regarding brain functions and this disorder. Processes that are associated with central executive processing are
 
  associated with brain activity located in the ________ area of the prefrontal cortex that seems to be dysfunctional in schizophrenia.
 
  a. preoptic
  b. dorsolateral
  c. verbal
  d. posterior

Question 2

Research on the relationship between dysfunctional smooth-pursuit eye movement and schizophrenia has suggested that this dysfunction may be
 
  a. absent in other mental disorders.
  b. induced by an environmental toxin.
  c. present in all forms of schizophrenia.
  d. associated with a predisposition to schizophrenia.



nmyers

  • Sr. Member
  • ****
  • Posts: 336
Answer to Question 1

Answer: b.

Answer to Question 2

Answer: d.



Related Topics

Need homework help now?

Ask unlimited questions for free

Ask a Question
 

Did you know?

Long-term mental and physical effects from substance abuse include: paranoia, psychosis, immune deficiencies, and organ damage.

Did you know?

A headache when you wake up in the morning is indicative of sinusitis. Other symptoms of sinusitis can include fever, weakness, tiredness, a cough that may be more severe at night, and a runny nose or nasal congestion.

Did you know?

The types of cancer that alpha interferons are used to treat include hairy cell leukemia, melanoma, follicular non-Hodgkin's lymphoma, and AIDS-related Kaposi's sarcoma.

Did you know?

Certain topical medications such as clotrimazole and betamethasone are not approved for use in children younger than 12 years of age. They must be used very cautiously, as directed by a doctor, to treat any child. Children have a much greater response to topical steroid medications.

Did you know?

The Food and Drug Administration has approved Risperdal, an adult antipsychotic drug, for the symptomatic treatment of irritability in children and adolescents with autism. The approval is the first for the use of a drug to treat behaviors associated with autism in children. These behaviors are included under the general heading of irritability and include aggression, deliberate self-injury, and temper tantrums.

For a complete list of videos, visit our video library